CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing a new platform for producing and modifying extracellular vesicles for drug delivery. By utilizing natural sources, it aims to create effective nanocarriers that can deliver therapeutics across biological barriers, enhancing applications in medicine, cosmetics, and nutrition.
Extracellular vesicles (EVs) are cell-derived, membranous particles that mediate intercellular communication by transferring biomolecules such as proteins and RNAs.
The discovery of EVs as natural biocarriers and inter-species communication means has raised great interest in the drug delivery field. EVs intrinsically possess many attributes of a drug delivery vehicle, since these particles i) are well tolerated in the body, ii) have long circulating half-life, iii) are internalised by recipient…
CONSIGLIO NAZIONALE DELLE RICERCHE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
OLLSCOIL TEICNEOLAIOCHTA AN ATLANTAIGH
Ireland, LETTERKENNY
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Zuerich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Slovenia, Ljubljana
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
